SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 12, 2023
Document Date
Apr 10, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.
Filer
Azelby Robert

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com